JPWO2021185890A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021185890A5
JPWO2021185890A5 JP2022556000A JP2022556000A JPWO2021185890A5 JP WO2021185890 A5 JPWO2021185890 A5 JP WO2021185890A5 JP 2022556000 A JP2022556000 A JP 2022556000A JP 2022556000 A JP2022556000 A JP 2022556000A JP WO2021185890 A5 JPWO2021185890 A5 JP WO2021185890A5
Authority
JP
Japan
Prior art keywords
weight
extract
composition
ginsenosides
total ginsenosides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022556000A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023519189A5 (https=
JP7850670B2 (ja
JP2023519189A (ja
Publication date
Priority claimed from GBGB2004121.6A external-priority patent/GB202004121D0/en
Priority claimed from GBGB2005288.2A external-priority patent/GB202005288D0/en
Application filed filed Critical
Priority claimed from PCT/EP2021/056788 external-priority patent/WO2021185890A1/en
Publication of JP2023519189A publication Critical patent/JP2023519189A/ja
Publication of JP2023519189A5 publication Critical patent/JP2023519189A5/ja
Publication of JPWO2021185890A5 publication Critical patent/JPWO2021185890A5/ja
Application granted granted Critical
Publication of JP7850670B2 publication Critical patent/JP7850670B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022556000A 2020-03-20 2021-03-17 ギンセノシド組成物 Active JP7850670B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB2004121.6A GB202004121D0 (en) 2020-03-20 2020-03-20 Improved compositions
GB2004121.6 2020-03-20
GBGB2005288.2A GB202005288D0 (en) 2020-04-09 2020-04-09 Improved compositions
GB2005288.2 2020-04-09
PCT/EP2021/056788 WO2021185890A1 (en) 2020-03-20 2021-03-17 Ginsenoside compositions

Publications (4)

Publication Number Publication Date
JP2023519189A JP2023519189A (ja) 2023-05-10
JP2023519189A5 JP2023519189A5 (https=) 2024-03-27
JPWO2021185890A5 true JPWO2021185890A5 (https=) 2024-03-27
JP7850670B2 JP7850670B2 (ja) 2026-04-23

Family

ID=75108332

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022556000A Active JP7850670B2 (ja) 2020-03-20 2021-03-17 ギンセノシド組成物
JP2022555990A Active JP7808042B2 (ja) 2020-03-20 2021-03-17 ギンセノシド組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022555990A Active JP7808042B2 (ja) 2020-03-20 2021-03-17 ギンセノシド組成物

Country Status (8)

Country Link
US (2) US20230124503A1 (https=)
EP (2) EP4121061A1 (https=)
JP (2) JP7850670B2 (https=)
CN (2) CN115315266A (https=)
AU (2) AU2021238639A1 (https=)
BR (2) BR112022015826A2 (https=)
CA (2) CA3174699A1 (https=)
WO (2) WO2021185890A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021185890A1 (en) * 2020-03-20 2021-09-23 Givaudan Sa Ginsenoside compositions
CN117224553B (zh) * 2023-11-02 2025-08-12 浙江大学 人参皂苷Rg3在制备治疗或预防肠道病毒感染的药物中的应用
CN117752706B (zh) * 2023-12-20 2025-10-14 浙江天皇药业有限公司 西洋参炮制品在制备治疗甲状腺功能减退症药物中的应用
WO2025261873A1 (en) 2024-06-20 2025-12-26 Givaudan Sa Improvements in or relating to compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202731A1 (en) * 2003-04-08 2004-10-14 Gow Robert T. Rosmarinic acid composition
US9956241B2 (en) * 2009-05-04 2018-05-01 Naturex, S.A. Application of American Ginseng to enhance neurocognitive function
US20100278944A1 (en) 2009-05-04 2010-11-04 Naturex, S.A. Application of american ginseng to enhance neurocognitive function
US10456436B2 (en) * 2013-11-04 2019-10-29 Wen Luan Wendy Hsiao Use of herbal saponins to regulate gut microflora
JP7223754B2 (ja) 2017-07-18 2023-02-16 セネッセンス ライフ サイエンセズ プライベート リミテッド 認知機能の低下の治療および予防、また神経機能の保持に関する組成物およびその方法。
CN110613802A (zh) 2018-06-20 2019-12-27 珠海岐微生物科技有限公司 白茅根大黄炭三七组合物及其在调节肠道微生物中的用途
CN109432304A (zh) * 2018-12-03 2019-03-08 杭州胡庆余堂药业有限公司 一种含铁皮石斛组合物在药物制备中的应用
WO2021185890A1 (en) 2020-03-20 2021-09-23 Givaudan Sa Ginsenoside compositions

Similar Documents

Publication Publication Date Title
TW470647B (en) Composition and pharmaceutical combination kit comprising formoterol and budesonide
JP2020527583A5 (https=)
JP2019511488A5 (https=)
CN111419861B (zh) 治疗血管性痴呆病的中药有效成分复方制剂及其应用
Tønnesen et al. Bronchodilating effect of terbutaline powder in acute severe bronchial obstruction
Zhang et al. Antiviral Potential of the Genus Panax: An updated review on their effects and underlying mechanism of action
US20220387455A1 (en) Treatment of moderate to severe influenza
US20070244079A1 (en) Preventive/remedy for allergic diseases
JPWO2021185890A5 (https=)
CN104013638A (zh) 当药黄素及其衍生物的用途
Schultze-Werninghaus Multicenter 1-year trial on formoterol, a new long-acting β 2-agonist, in chronic obstructive airway disease
JP2009510051A5 (https=)
CN117159679A (zh) 一种治疗流感的中药组合物及其制备方法和应用
CN112535668B (zh) 一种左旋硫酸沙丁胺醇颗粒剂及其用途
Cox et al. The Oral effects of inhalation corticosteroid therapy: an update
Chaplin et al. Relvar Ellipta: new once‐daily steroid/LABA inhaler
CN115835862A (zh) 治疗阿尔茨海默病的组合及其应用
JPWO2021185897A5 (https=)
Ellipta Relvar Ellipta: new once-daily steroid/LABA inhaler
JP4221266B2 (ja) アレルギー性疾患の症状を抑制・緩和するための薬剤
WO2020207398A1 (zh) 银杏萜内酯在制备预防和/或治疗吉兰-巴雷综合征药物中的用途
CN103877554A (zh) 一种治疗心脏病的药物组合物及其制备方法和用途
CN101028338B (zh) 一种治疗心血管疾病的口腔崩解片及制备方法
Rabe et al. Benefits of tiotropium/olodaterol over tiotropium alone in delaying clinically significant deterioration in patients with COPD
Trapnell et al. Inhaled GM-CSF (Molgramostim) Therapy Reduces the Need for Whole Lung Lavage in Patients with Autoimmune Pulmonary Alveolar Proteinosis-Long-Term Results from a Randomized, Double-Blind Trial (IMPALA)